Avalo Therapeutics CFO Christopher Ryan Sullivan disposes of 10,185 common shares worth $179,485.72 - AVTX News | RalliesAvalo Therapeutics CFO Christopher Ryan Sullivan disposes of 10,185 common shares worth $179,485.72
A
AVTX• CFO share transaction
- Avalo Therapeutics CFO Christopher Ryan Sullivan exercised stock options for 10,185 common shares at $8.04 on Sept. 10.
- He sold 10,185 common shares at $17.62, cutting his direct stake to 39,900 shares.
- Derivative holdings fell to 105,815 stock options following the transaction.
PLMR
•
